(Q46609020)

23 December 2017

title

Reconstructing exposures from small samples using physiologically based pharmacokinetic models and multiple biomarkers (English)

1 reference

23 December 2017

1 reference

1

1 reference

23 December 2017

author name string

Amy Collins Licata

2

1 reference

23 December 2017

Bing Liu

3

1 reference

23 December 2017

Susan C J Sumner

4

1 reference

23 December 2017

Miles S Okino

5

1 reference

23 December 2017

publication date

7 May 2008

1 reference

23 December 2017

Journal of Exposure Analysis and Environmental Epidemiology

published in

1 reference

23 December 2017

volume

19

1 reference

23 December 2017

page(s)

284-297

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/jes.2008.17

exact match

0 references

cites work

Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Concentrations of selective metabolites of organophosphorus pesticides in the United States population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Physiological parameter values for physiologically based pharmacokinetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Determinants of temporal variability in NHEXAS-Maryland environmental concentrations, exposures, and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Exposure to the organophosphate diazinon: data from a human volunteer study with oral and dermal doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Oral and dermal absorption of chlorpyrifos: a human volunteer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Strategies for use of biological markers of exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Exposures of preschool children to chlorpyrifos and its degradation product 3,5,6-trichloro-2-pyridinol in their everyday environments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Case studies of the use of biomarkers to assess exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Analysis of aggregate exposure to chlorpyrifos in the NHEXAS-Maryland investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Use of a pharmacokinetic model to assess chlorpyrifos exposure and dose in children, based on urinary biomarker measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Biotransformation of chlorpyrifos and diazinon by human liver microsomes and recombinant human cytochrome P450s (CYP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Monte Carlo analysis of the human chlorpyrifos-oxonase (PON1) polymorphism using a physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Aggregate exposures of nine preschool children to persistent organic pollutants at day care and at home

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

7 January 2021

Chlorpyrifos: Pharmacokinetics in human volunteers

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

7 January 2021

Physiologically Based Pharmacokinetic Modeling

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

7 January 2021

Mammalian toxicology of organophosphorus pesticides.

1 reference

https://api.crossref.org/works/10.1038%2FJES.2008.17

7 January 2021

Identifiers

DOI

10.1038/JES.2008.17

1 reference

23 December 2017

PubMed ID

18461092

1 reference

23 December 2017